Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1
Genes · 01.08.2023 · 14 (8) · 1569
DOI: 10.3390/genes14081569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 01.08.2023. Verfasst von Pier-Angelo Tovo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Chronic immune thrombocytopenia (CITP) is an autoimmune disease whose underlying biologic mechanisms remain elusive. Human endogenous retroviruses (HERVs) derive from ancestral infections and constitute about 8% of our genome. A wealth of clinical and experimental studies highlights their pivotal pathogenetic role in autoimmune diseases. Epigenetic mechanisms, such as those modulated by TRIM28 and SETDB1, are involved in HERV activation and regulation of immune response. We assessed, through a polymerase chain reaction real-time Taqman amplification assay, the transcription levels of pol genes of HERV-H, HERV-K, and HERV-W; env genes of Syncytin (SYN)1, SYN2, and HERV-W; as well as TRIM28 and SETDB1 in whole blood from 34 children with CITP and age-matched healthy controls (HC). The transcriptional levels of all HERV sequences, with the exception of HERV-W-env, were significantly enhanced in children with CITP as compared to HC. Patients on eltrombopag treatment exhibited lower expression of SYN1, SYN2, and HERV-W-env as compared to untreated patients. The mRNA concentrations of TRIM28 and SETDB1 were significantly higher and were positively correlated with those of HERVs in CITP patients. The over-expressions of HERVs and TRIM28/SETDB1 and their positive correlations in patients with CITP are suggestive clues of their contribution to the pathogenesis of the disease and support innovative interventions to inhibit HERV and TRIM28/SETDB1 expressions in patients unresponsive to standard therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
- Pediatric Laboratory, Department of Public Health and Pediatric Sciences, University of Turin, Regina Margherita Children's Hospitalno, Piazza Polonia 94, 10126 Turin, Italy.
- Pediatric and Neonatology Unit, Ordine Mauriziano Hospital, Largo Filippo Turati 62, 10128 Turin, Italy.
- Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.
- Postgraduate School of Pediatrics, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
ORCID-Profile: Francesco Licciardi
Zitieren
APA
Tovo, P. A., Galliano, I., Parodi, E., Calvi, C., Gambarino, S., Licciardi, F., Dini, M., Montanari, P., Branca, M., Ramenghi, U., & Bergallo, M. (2023). Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1. Genes, 14(8), 1569. https://doi.org/10.3390/genes14081569
Vancouver
Tovo PA, Galliano I, Parodi E, Calvi C, Gambarino S, Licciardi F, et al. Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1. Genes. 2023;14(8):1569. doi:10.3390/genes14081569
BibTeX
@article{Tovo2023,
author = {Tovo, Pier-Angelo and Galliano, Ilaria and Parodi, Emilia and Calvi, Cristina and Gambarino, Stefano and Licciardi, Francesco and Dini, Maddalena and Montanari, Paola and Branca, Margherita and Ramenghi, Ugo and Bergallo, Massimiliano},
title = {Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1},
journal = {Genes},
year = {2023},
volume = {14},
number = {8},
pages = {1569},
doi = {10.3390/genes14081569}
}
EUVIMED